News
Elanco Innovation Builds Momentum, Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) Reaches Blockbuster Status
Published: September 9, 2025
Elanco Animal Health Incorporated (NYSE: ELAN) has announced significant advancements with its two most recent pet health innovations — Credelio Quattro and Zenrelia — further demonstrating the company’s commitment to helping pet owners and veterinarians around the world Read More